Precision medicine offers more targeted treatments, better patient outcomes, and even the potential to transform how we approach disease. But getting there isn’...
Continue reading
In rare and ultra-rare diseases, data availability is one of the most significant constraints in research and drug development. With thousands of rare condition...
Continue reading
In the latest episode of The Genetics Podcast, Patrick Short chatted with Leeland Ekstrom, CEO and co-founder of Nashville Biosciences (NashBio), a for-profit s...
Continue reading
Hearing loss affects over 1.5 billion people worldwide, with nearly half of all cases linked to genetic factors. Despite this, diagnosis and treatment options h...
Continue reading
In the latest episode of The Genetics Podcast, Patrick spoke with Dr. John Lepore, physician-scientist and CEO of ProFound Therapeutics. ProFound Therapeutics, ...
Continue reading
For decades, treatment for congenital and genetic hearing loss has largely relied on devices such as hearing aids and cochlear implants. While these technologie...
Continue reading
Diagnosing genetic hearing loss hasn’t always been straightforward. With so many different causes and overlapping symptoms, traditional methods have often strug...
Continue reading
.png)
In last week’s episode of The Genetics Podcast, Patrick spoke with Jocelynn Pearl, Director of Cancer Cell Therapy at the TAM Center. With a career spanning gen...
Continue reading
In precision medicine trials, recruitment and compliance are interdependent workstreams. Every step that brings a patient closer to enrollment, from digital out...
Continue reading